Nov 16, 2020
Tryp Appoints Dr. Jim Gilligan, PhD, MBIS, as President and Chief Scientific Officer
Sep 6, 2020
Tryp Therapeutics Announces Formation of Psilocybin Scientific Advisory Board
Aug 13, 2020
Tryp Therapeutics Partners with Albany Molecular Research Inc. to Manufacture a Proprietary Psilocybin-based Drug
© 2020
All rights reserved.
Disclaimer